Chargement en cours...
Current advancements in promoting remyelination in multiple sclerosis
Current multiple sclerosis (MS) therapies are effective in reducing the rate of relapse, short-term measures of disability, and MRI measures of inflammation, whereas in progressive/degenerative disease phases, these medications are of little or no benefit. Therefore, the development of new therapies...
Enregistré dans:
| Publié dans: | Mult Scler |
|---|---|
| Auteurs principaux: | , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6389436/ https://ncbi.nlm.nih.gov/pubmed/30270725 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1352458518800827 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|